Medical Developments International | MVP - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.01M 175K 2026-03
Avita Medical AUD 28.02M 1.55M 2025-12
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Dianthus Therapeutics USD 47M 22.83M 2026-03
Genetic Signatures AUD 17.52M 9.22M 2025-12
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Medical Developments International AUD 21.61M 11.59M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Organon & Co USD 1.01B 103M 2026-06
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Tectonic Therapeutic USD 27.3M 5.78M 2026-03
Telix Pharmaceuticals AUD 430.99M 25.59M 2026-06
Viatris USD 3.68B 145.9M 2026-06
Xeris Pharmaceuticals USD 75.21M 6.18M 2026-03